NYSE · JIndustrialsConstruction

Jacobs Solutions financials

$136.48−1.37%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ3 '26
Jun 26
Q2 '26
Mar 27
Q1 '26
Dec 26
Q4 '25
Sep 26
Q3 '25
Jun 27
Q2 '25
Mar 28
Q1 '25
Dec 27
Q4 '24
Sep 27
Q3 '24
Jun 28
Q2 '24
Mar 29
Q1 '24
Dec 29
Q4 '23
Sep 29
Revenue$4.08B$3.69B$3.29B$3.15B$3.03B$2.91B$2.93B$2.96B$2.88B$2.85B$2.81B$4.29B
Gross profit$810.7M$794.9M$765.3M$766.9M$758.4M$738.3M$721.3M$735.1M$720.9M$712.0M$664.7M$911.6M
Gross margin19.9%21.5%23.2%24.3%25.0%25.4%24.6%24.8%25.0%25.0%23.7%21.3%
Operating income$286.7M-$81.2M$232.6M$211.6M$235.0M$208.6M$208.4M$196.2M$171.0M$183.2M$142.0M$277.8M
Net income$136.6M-$40.1M$133.2M$110.7M$186.2M$6.9M-$13.6M$313.4M$146.9M$162.1M$173.4M$157.7M
Net margin3.3%−1.1%4.0%3.5%6.1%0.2%−0.5%10.6%5.1%5.7%6.2%3.7%
Diluted EPS$1.15$-0.34$1.12$0.92$1.55$0.06$-0.11$2.51$1.17$1.28$1.37$1.24
EBITDA$343.9M-$24.9M$292.2M$271.1M$295.3M$266.7M$268.0M$274.5M$248.0M$260.4M$218.3M$277.8M
Operating cash flow$456.1M-$484.1M$380.8M$383.1M$292.6M-$96.4M$107.5M$196.5M$482.6M-$42.8M$418.4M$219.4M
Free cash flow$431.0M-$504.9M$364.9M$353.5M$270.5M-$113.7M$97.1M$158.2M$444.9M-$70.6M$401.1M$180.1M
Diluted shares118.9M117.3M119.0M120.6M120.5M122.6M124.1M124.9M125.6M126.2M126.8M126.9M

Balance sheet

Period endJun 26Mar 27Dec 26Sep 26Jun 27Mar 28
Cash & equivalents$1.17B$1.37B$1.55B$1.24B$1.29B$1.20B
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$3.58B$4.08B$2.49B$2.24B$2.51B$2.63B
Total assets$11.74B$11.94B$11.61B$11.25B$11.41B$11.21B
Total liabilities$8.49B$8.66B$7.07B$6.59B$6.67B$6.52B
Shareholders' equity$3.25B$3.28B$3.45B$3.65B$3.83B$3.87B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology